Abstract
BACKGROUND: In patients with the Zollinger-Ellison syndrome, the exclusion of multiple endocrine neoplasia type 1 is of important clinical relevance. Its diagnosis often relies on the existence of primary hyperparathyroidism. AIM AND METHODS: To investigate the parathyroid function of patients with the Zollinger-Ellison syndrome by use of an oral calcium tolerance test to identify both hypercalcaemic and normocalcaemic primary hyperparathyroidism, and, accordingly, multiple endocrine neoplasia type 1. PATIENTS: Among 51 consecutive patients with the Zollinger-Ellison syndrome referred to us between 1988 and 1994, 28 had not been investigated for parathyroid function and were prospectively studied. RESULTS: The investigation of calcium metabolism was abnormal in nine patients. One displayed characteristic features of humoral hypercalcaemia of malignancy. The diagnosis of primary hyperparathyroidism was biologically established in eight patients (29%) and subsequently confirmed by the presence of hyperplasia of the parathyroid glands in the seven patients who underwent neck exploration. Three patients with primary hyperparathyroidism had fasting hyper-calcaemia but the other five had normal fasting serum total calcium concentration and the diagnosis of primary hyperparathyroidism was established by means of the oral calcium tolerance test. Primary hyperparathyroidism was demonstrated in the five patients in whom the diagnosis of multiple endocrine neoplasia type 1 had been previously established on other criteria than primary hyperparathyroidism. By contrast, in three patients, primary hyperparathyroidism, either hypercalcaemic (one patient) or normocalcaemic (two patients) was the sole criteria for the diagnosis of multiple endocrine neoplasia type 1. These results also suggest that primary hyperparathyroidism is present before or close to the time of Zollinger-Ellison syndrome diagnosis. CONCLUSION: Complete investigation of the parathyroid function with calcium calcium and parathyroid hormone concentrations.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andersen D. K. Current diagnosis and management of Zollinger-Ellison syndrome. Ann Surg. 1989 Dec;210(6):685–703. doi: 10.1097/00000658-198912000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Benya R. V., Metz D. C., Venzon D. J., Fishbeyn V. A., Strader D. B., Orbuch M., Jensen R. T. Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I. Am J Med. 1994 Nov;97(5):436–444. doi: 10.1016/0002-9343(94)90323-9. [DOI] [PubMed] [Google Scholar]
- Broadus A. E., Horst R. L., Littledike E. T., Mahaffey J. E., Rasmussen H. Primary hyperparathyroidism with intermittent hypercalcaemia: serial observations and simple diagnosis by means of an oral calcium tolerance test. Clin Endocrinol (Oxf) 1980 Mar;12(3):225–235. doi: 10.1111/j.1365-2265.1980.tb02704.x. [DOI] [PubMed] [Google Scholar]
- Broadus A. E., Mahaffey J. E., Bartter F. C., Neer R. M. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J Clin Invest. 1977 Oct;60(4):771–783. doi: 10.1172/JCI108831. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Farley D. R., van Heerden J. A., Grant C. S., Miller L. J., Ilstrup D. M. The Zollinger-Ellison syndrome. A collective surgical experience. Ann Surg. 1992 Jun;215(6):561–570. doi: 10.1097/00000658-199206000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gardin J. P., Paillard M. Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium. Miner Electrolyte Metab. 1984;10(5):301–308. [PubMed] [Google Scholar]
- Lamers C. B. Gastrinoma in multiple endocrine neoplasia type 1. Acta Oncol. 1991;30(4):489–492. doi: 10.3109/02841869109092406. [DOI] [PubMed] [Google Scholar]
- Melvin W. S., Johnson J. A., Sparks J., Innes J. T., Ellison E. C. Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia. Surgery. 1993 Dec;114(6):1183–1188. [PubMed] [Google Scholar]
- Mignon M., Bonfils S. Diagnosis and treatment of Zollinger-Ellison syndrome. Baillieres Clin Gastroenterol. 1988 Jul;2(3):677–698. doi: 10.1016/s0950-3528(88)80013-7. [DOI] [PubMed] [Google Scholar]
- Monchik J. M., Lamberton R. P., Roth U. Role of the oral calcium-loading test with measurement of intact parathyroid hormone in the diagnosis of symptomatic subtle primary hyperparathyroidism. Surgery. 1992 Dec;112(6):1103–1110. [PubMed] [Google Scholar]
- Norton J. A., Cornelius M. J., Doppman J. L., Maton P. N., Gardner J. D., Jensen R. T. Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. Surgery. 1987 Dec;102(6):958–966. [PubMed] [Google Scholar]
- Nussbaum S. R., Zahradnik R. J., Lavigne J. R., Brennan G. L., Nozawa-Ung K., Kim L. Y., Keutmann H. T., Wang C. A., Potts J. T., Jr, Segre G. V. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987 Aug;33(8):1364–1367. [PubMed] [Google Scholar]
- Patron P., Gardin J. P., Paillard M. Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism. Kidney Int. 1987 May;31(5):1174–1180. doi: 10.1038/ki.1987.125. [DOI] [PubMed] [Google Scholar]
- Ruszniewski P., Podevin P., Cadiot G., Marmuse J. P., Mignon M., Vissuzaine C., Bonfils S., Lehy T. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas. 1993 May;8(3):295–304. doi: 10.1097/00006676-199305000-00003. [DOI] [PubMed] [Google Scholar]
- Sheppard B. C., Norton J. A., Doppman J. L., Maton P. N., Gardner J. D., Jensen R. T. Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study. Surgery. 1989 Dec;106(6):1108–1118. [PubMed] [Google Scholar]
- Thompson N. W., Bondeson A. G., Bondeson L., Vinik A. The surgical treatment of gastrinoma in MEN I syndrome patients. Surgery. 1989 Dec;106(6):1081–1086. [PubMed] [Google Scholar]
- Yendt E. R., Gagne R. J. Detection of primary hyperparathyroidism, with special reference to its occurrence in hypercalciuric females with "normal" or borderline serum calcium. Can Med Assoc J. 1968 Feb 17;98(7):331–336. [PMC free article] [PubMed] [Google Scholar]